nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse drug reactions associated with immune checkpoint inhibitors: An exploratory nested case-control study in a historical cohort
|
Pluye, Manon |
|
|
78 |
3 |
p. 303-311 |
artikel |
2 |
Case report: Confirming a diagnosis of severe olmesartan-associated enteropathy
|
Roulet, Lucien |
|
|
78 |
3 |
p. 338-342 |
artikel |
3 |
COVID-19: Global inequality in science
|
Elango, Bakthavachalam |
|
|
78 |
3 |
p. 325-327 |
artikel |
4 |
Editorial board
|
|
|
|
78 |
3 |
p. i |
artikel |
5 |
Histoire de la pharmacologie–toxicologie à Limoges
|
Marquet, Pierre |
|
|
78 |
3 |
p. 229-234 |
artikel |
6 |
Hospitalisations après consommation de substances psychoactives pendant la pandémie de COVID-19
|
Dumoulin, Claire |
|
|
78 |
3 |
p. 334-338 |
artikel |
7 |
Immune thrombocytopenia following ChAdOx1 vaccine and positive rechallenge with BNT162b2 vaccine: A case report with pharmacovigilance analysis
|
Murarasu, Anne |
|
|
78 |
3 |
p. 328-330 |
artikel |
8 |
Impact of diabetes mellitus on rifampicin's plasma concentration and bioavailability in patients with tuberculosis: A systematic review and meta-analysis study
|
El-Sheikh, Sawsan M.A. |
|
|
78 |
3 |
p. 313-324 |
artikel |
9 |
Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses’ infections
|
Ghrieb, Zineb |
|
|
78 |
3 |
p. 241-245 |
artikel |
10 |
Les demandes d’analyses des caractéristiques génétiques par séquençage dans les recherches cliniques : considérations juridiques et éthiques
|
Desbrest, Bertille |
|
|
78 |
3 |
p. 247-257 |
artikel |
11 |
Minors and young adult's hospitalizations after “chimique” consumption in Mayotte Island: Which substances are involved?
|
Goncalves, Ruben |
|
|
78 |
3 |
p. 235-240 |
artikel |
12 |
Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients
|
Gendarme, Sébastien |
|
|
78 |
3 |
p. 267-278 |
artikel |
13 |
Érythème noueux associé au vaccin Tozinaméran : à propos de 2 cas et revue de la littérature
|
Berrim, Khouloud |
|
|
78 |
3 |
p. 330-334 |
artikel |
14 |
Some comments about public perception of drug risk
|
Bouvenot, Gilles |
|
|
78 |
3 |
p. 225-227 |
artikel |
15 |
The relationship between relative telomere length and anti-tuberculosis drug-induced hepatitis : A case-control study
|
Liu, Wenpei |
|
|
78 |
3 |
p. 259-266 |
artikel |
16 |
The winding 12-month journey of the AstraZeneca COVID-19 vaccine since its first administration to humans
|
Dal-Ré, Rafael |
|
|
78 |
3 |
p. 293-302 |
artikel |
17 |
Vaccines and Bell's palsy: A narrative review
|
Bertin, Blandine |
|
|
78 |
3 |
p. 279-292 |
artikel |